Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

44.4%

4 terminated/withdrawn out of 9 trials

Success Rate

55.6%

-30.9% vs industry average

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

3(37.5%)

Phase 3

3(37.5%)

Phase 1

2(25.0%)

8Total

Phase 2(3)

Phase 3(3)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT00766181Terminated

Satisfaction With Pediatric Intravenous Catheter Placement in the Emergency Department

Role: lead

NCT00656578Phase 3Completed

Efficacy and Safety Study of 4975 to Manage Pain of Bunionectomy

Role: lead

NCT00672568Phase 2Terminated

Safety and Tolerability of 4975 in Patients Undergoing Arthroscopic Surgery to Repair the Rotator Cuff of the Shoulder

Role: lead

NCT00683267Phase 2Terminated

Efficacy and Safety Study of 4975 in Patients Undergoing Total Hip Replacement

Role: lead

NCT00681356Phase 3Completed

Safety and Efficacy Study of 4975 in Patients Undergoing Total Knee Replacement

Role: lead

NCT00125333Phase 1Completed

Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis

Role: lead

NCT00042081Phase 3Completed

Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures

Role: lead

NCT00086164Phase 1Terminated

Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis

Role: lead

NCT00041925Phase 2Completed

Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures

Role: lead

All 9 trials loaded